75th Cellular, Tissue, and Gene Therapies Advisory Committee
Recent CMC Guidance for Cellular and Gene Therapies: BIO-ASGCT CGT Science Series
FDA’s Efforts to Advance the Development and Approval of Cellular and Gene Therapies
The FDA's Role in Gene Therapy
74th Cellular, Tissue, and Gene Therapies Advisory Committee
Regulatory considerations for Cell and Gene Therapies - Jim DeKloe
Emcure_InnovationsInHematology
Navigating regulatory challenges for cell and gene therapy products in 2024 and beyond
Cell & Gene Therapy Products 2022 Keynote: Peter Marks, CBER, FDA
Understanding Cell & Gene Therapy: Types and Techniques Explained
What are Cell and Gene Therapies?
Gene Therapy Basics (2022 Update)
Cell and Gene Therapy: Advancing the Next Generation of Pharmaceuticals
Advanced Topics Successful Development of Quality Cell and Gene Therapy Products
Why the FDA’s approval of revolutionary sickle cell gene therapy is a ‘big deal’
Expediting the Development of Cell and Gene Therapy
Lunch & Learn: Gene Therapy 101
72nd Cellular, Tissue and Gene Therapies Advisory Committee - Day 1
Cell and Gene Therapy Solutions: Enabling PSC Translation Workflows
FDA Regulation of Cell and Gene Therapies: Facilitating Advanced Manufacturing
